An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes. (Q51854357)

14 April 2018

title

An increased frequency of NK cell receptor and HLA-C group 1 combinations in early-onset type 1 diabetes. (English)

1 reference

14 April 2018

0 references

10

P J Bingley

1 reference

14 April 2018

author name string

K L Mehers

1

1 reference

14 April 2018

A E Long

2

1 reference

14 April 2018

A R van der Slik

3

1 reference

14 April 2018

R J Aitken

4

1 reference

14 April 2018

V Nathwani

5

1 reference

14 April 2018

F S Wong

6

1 reference

14 April 2018

S Bain

7

1 reference

14 April 2018

G Gill

8

1 reference

14 April 2018

B O Roep

9

1 reference

14 April 2018

K M Gillespie

11

1 reference

14 April 2018

publication date

10 September 2011

1 reference

14 April 2018

published in

Diabetologia

1 reference

14 April 2018

volume

54

1 reference

14 April 2018

issue

12

1 reference

14 April 2018

page(s)

3062-3070

1 reference

14 April 2018

Immunoregulatory dysfunctions in type I diabetes: natural and antibody-dependent cellular cytotoxic activities

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Human diversity in killer cell inhibitory receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

KIR: diverse, rapidly evolving receptors of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Killer Ig-like receptor (KIR) genotype and HLA ligand combinations in ulcerative colitis susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

ALSPAC--the Avon Longitudinal Study of Parents and Children. I. Study methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Humans Differ from Other Hominids in Lacking an Activating NK Cell Receptor That Recognizes the C1 Epitope of MHC Class I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Altered natural killer cells in type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Analysis of islet inflammation in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

The activating receptor NKp46 is essential for the development of type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Killer Cell Immunoglobulin-Like Receptor (KIR) Genes in the Basque Population: Association Study of KIR Gene Contents With Type 1 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2299-X

Diabetes diagnosed before the age of 2 years: mortality in a British cohort 8-17 years after onset

21 January 2018

1 reference

12 December 2020

Natural killer cells in insulin dependent diabetes mellitus

1 reference

12 December 2020

Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined

1 reference

12 December 2020

Genetic associations in Italian primary sclerosing cholangitis: heterogeneity across Europe defines a critical role for HLA-C

1 reference

12 December 2020

The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes

1 reference

12 December 2020

Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles

1 reference

12 December 2020

Modelling KIR-HLA genotype disparities in type 1 diabetes

1 reference

12 December 2020

Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

Investigation of KIR gene frequencies in type 1 diabetes mellitus

1 reference

12 December 2020

Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena

1 reference

12 December 2020

Cytotoxic activity in children with insulin-dependent diabetes mellitus

1 reference

12 December 2020

KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects

1 reference

12 December 2020

10.1007/S00125-011-2299-X

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018